• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的CHO细胞培养强化:从补料分批培养到灌注培养的一步式策略。

Model-based intensification of CHO cell cultures: One-step strategy from fed-batch to perfusion.

作者信息

Richelle Anne, Corbett Brandon, Agarwal Piyush, Vernersson Anton, Trygg Johan, McCready Chris

机构信息

Sartorius Corporate Research, Brussels, Belgium.

Sartorius Corporate Research, Toronto, ON, Canada.

出版信息

Front Bioeng Biotechnol. 2022 Aug 22;10:948905. doi: 10.3389/fbioe.2022.948905. eCollection 2022.

DOI:10.3389/fbioe.2022.948905
PMID:36072286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9443430/
Abstract

There is a growing interest in continuous processing of the biopharmaceutical industry. However, the technology transfer from traditional batch-based processes is considered a challenge as protocol and tools still remain to be established for their usage at the manufacturing scale. Here, we present a model-based approach to design optimized perfusion cultures of Chinese Hamster Ovary cells using only the knowledge captured during small-scale fed-batch experiments. The novelty of the proposed model lies in the simplicity of its structure. Thanks to the introduction of a new catch-all variable representing a bulk of by-products secreted by the cells during their cultivation, the model was able to successfully predict cellular behavior under different operating modes without changes in its formalism. To our knowledge, this is the first experimentally validated model capable, with a single set of parameters, to capture culture dynamic under different operating modes and at different scales.

摘要

生物制药行业对连续加工的兴趣日益浓厚。然而,从传统的分批工艺进行技术转移被认为是一项挑战,因为在制造规模上使用它们的协议和工具仍有待建立。在这里,我们提出了一种基于模型的方法,仅使用小规模补料分批实验中获得的知识来设计优化的中国仓鼠卵巢细胞灌注培养。所提出模型的新颖之处在于其结构的简单性。由于引入了一个新的总括变量,该变量代表细胞在培养过程中分泌的大量副产物,该模型能够在不改变其形式主义的情况下成功预测不同操作模式下的细胞行为。据我们所知,这是第一个经过实验验证的模型,能够用一组参数捕捉不同操作模式和不同规模下的培养动态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/d528e160b0d0/fbioe-10-948905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/89f757647f8f/fbioe-10-948905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/7bc6c40cea37/fbioe-10-948905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/c6c9564d1667/fbioe-10-948905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/512d4c3250c4/fbioe-10-948905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/d528e160b0d0/fbioe-10-948905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/89f757647f8f/fbioe-10-948905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/7bc6c40cea37/fbioe-10-948905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/c6c9564d1667/fbioe-10-948905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/512d4c3250c4/fbioe-10-948905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/9443430/d528e160b0d0/fbioe-10-948905-g005.jpg

相似文献

1
Model-based intensification of CHO cell cultures: One-step strategy from fed-batch to perfusion.基于模型的CHO细胞培养强化:从补料分批培养到灌注培养的一步式策略。
Front Bioeng Biotechnol. 2022 Aug 22;10:948905. doi: 10.3389/fbioe.2022.948905. eCollection 2022.
2
Bioreactor productivity and media cost comparison for different intensified cell culture processes.不同强化细胞培养工艺的生物反应器生产力与培养基成本比较
Biotechnol Prog. 2017 Jul;33(4):867-878. doi: 10.1002/btpr.2415. Epub 2017 Jan 28.
3
Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing.生物制药一次性使用制造的风险评估:上游连续加工案例研究。
Biologicals. 2023 Nov;84:101713. doi: 10.1016/j.biologicals.2023.101713. Epub 2023 Oct 2.
4
Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.通过高密度灌注或强化补料分批培养来实现生产表达困难的治疗性酶的过程强化。
Biotechnol Bioeng. 2021 Sep;118(9):3533-3544. doi: 10.1002/bit.27806. Epub 2021 May 13.
5
Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.灌注种子培养提高了生物制药补料分批培养的生产能力和产品质量。
Biotechnol Prog. 2014 May-Jun;30(3):616-25. doi: 10.1002/btpr.1884. Epub 2014 Mar 3.
6
Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology.CHO补料分批培养中的前期灌注与超高接种细胞密度:以系统生物技术指导的过程强化为例
Bioprocess Biosyst Eng. 2020 Aug;43(8):1431-1443. doi: 10.1007/s00449-020-02337-1. Epub 2020 Apr 7.
7
Model-assisted Design of Experiments as a concept for knowledge-based bioprocess development.基于模型的实验设计作为知识型生物工艺开发的概念。
Bioprocess Biosyst Eng. 2019 May;42(5):867-882. doi: 10.1007/s00449-019-02089-7. Epub 2019 Feb 26.
8
Metabolic trends of Chinese hamster ovary cells in biopharmaceutical production under batch and fed-batch conditions.分批培养和补料分批培养条件下生物制药生产中中国仓鼠卵巢细胞的代谢趋势
Biotechnol Prog. 2022 Jan;38(1):e3220. doi: 10.1002/btpr.3220. Epub 2021 Nov 14.
9
Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.细胞控制的混合灌注补料分批CHO细胞工艺比传统补料分批培养显著提高了生产力。
Biotechnol Bioeng. 2017 Jul;114(7):1438-1447. doi: 10.1002/bit.26259. Epub 2017 Feb 9.
10
Probabilistic model by Bayesian network for the prediction of antibody glycosylation in perfusion and fed-batch cell cultures.基于贝叶斯网络的概率模型用于预测灌流和分批补料细胞培养中的抗体糖基化。
Biotechnol Bioeng. 2021 Sep;118(9):3447-3459. doi: 10.1002/bit.27769. Epub 2021 May 3.

引用本文的文献

1
Time-Resolved Hierarchical Modeling Highlights Metabolites Influencing Productivity and Cell Death in Chinese Hamster Ovary Cells.时间分辨层次建模揭示了影响中国仓鼠卵巢细胞生产力和细胞死亡的代谢物。
Biotechnol J. 2025 Mar;20(3):e202400624. doi: 10.1002/biot.202400624.
2
Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process.用于动态灌注细胞培养过程计算机模拟优化的混合建模
Biotechnol Prog. 2025 Jan-Feb;41(1):e3503. doi: 10.1002/btpr.3503. Epub 2024 Sep 18.

本文引用的文献

1
Enablers of continuous processing of biotherapeutic products.生物治疗产品连续加工的促成因素。
Trends Biotechnol. 2022 Jul;40(7):804-815. doi: 10.1016/j.tibtech.2021.12.003. Epub 2022 Jan 13.
2
A decade in review: use of data analytics within the biopharmaceutical sector.十年回顾:生物制药行业内数据分析的应用
Curr Opin Chem Eng. 2021 Dec;34:None. doi: 10.1016/j.coche.2021.100758.
3
Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture.影响重组中国仓鼠卵巢细胞培养中治疗性蛋白质质量的因素。
Biotechnol Adv. 2022 Jan-Feb;54:107831. doi: 10.1016/j.biotechadv.2021.107831. Epub 2021 Sep 2.
4
Process analytics 4.0: A paradigm shift in rapid analytics for biologics development.流程分析 4.0:生物制品开发中快速分析的范式转变。
Biotechnol Prog. 2021 Jul;37(4):e3177. doi: 10.1002/btpr.3177. Epub 2021 May 31.
5
When Is an In Silico Representation a Digital Twin? A Biopharmaceutical Industry Approach to the Digital Twin Concept.当计算机模型表示成为数字孪生时,会发生什么?一种生物制药行业对数字孪生概念的方法。
Adv Biochem Eng Biotechnol. 2021;176:35-55. doi: 10.1007/10_2020_138.
6
Impact of cell lysis on the description of cell growth and death in cell culture.细胞裂解对细胞培养中细胞生长和死亡描述的影响。
Eng Life Sci. 2016 Dec 12;17(4):440-447. doi: 10.1002/elsc.201600088. eCollection 2017 Apr.
7
Towards a Digital Bioprocess Replica: Computational Approaches in Biopharmaceutical Development and Manufacturing.迈向数字化生物工艺复制品:生物制药开发和制造中的计算方法。
Trends Biotechnol. 2020 Oct;38(10):1141-1153. doi: 10.1016/j.tibtech.2020.05.008. Epub 2020 Jun 6.
8
Developing a Computational Framework To Advance Bioprocess Scale-Up.开发推进生物工艺放大的计算框架。
Trends Biotechnol. 2020 Aug;38(8):846-856. doi: 10.1016/j.tibtech.2020.01.009. Epub 2020 Feb 25.
9
Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.引领制药行业的数字化转型:重塑全球药物研发的工作方式。
Clin Pharmacol Ther. 2020 Oct;108(4):756-761. doi: 10.1002/cpt.1850. Epub 2020 May 30.
10
An overview of drug discovery and development.药物发现与开发概述。
Future Med Chem. 2020 May;12(10):939-947. doi: 10.4155/fmc-2019-0307. Epub 2020 Apr 9.